1. Metabolic Enzyme/Protease
  2. Pyruvate Kinase
  3. PKM2-IN-1

PKM2-IN-1 (compound 3k) is a pyruvate kinase M2 (PKM2) inhibitor with an IC50 of 2.95 μM.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 94164-88-2

容量 価格(税別) 在庫状況 数量
>無料サンプル (0.1 - 0.2 mg)   今すぐ申し込む  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 105 在庫あり
Solution
10 mM * 1 mL in DMSO USD 105 在庫あり
Solid
5 mg $96 在庫あり
10 mg $120 在庫あり
25 mg $190 在庫あり
50 mg $245 在庫あり
100 mg $320 在庫あり
200 mg   お問い合わせ  
500 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 26 publication(s) in Google Scholar

Other Forms of PKM2-IN-1:

Top Publications Citing Use of Products

    PKM2-IN-1 purchased from MedChemExpress. Usage Cited in: Metabolism. 2025 Nov 6:175:156429.  [Abstract]

    Pyruvate kinase activities of B16F10 cells after incubation with MTyr–OANPs, MTyr–OANPs + PKM inhibitor PKM2-IN-1 and MTyr–OANPs + PKM activator TEPP-46.

    PKM2-IN-1 purchased from MedChemExpress. Usage Cited in: Metabolism. 2025 Nov 6:175:156429.  [Abstract]

    Cell viabilities of indole-5,6-quinone, indole-5,6-quinone + PKM inhibitor PKM2-IN-1 and indole 5,6-quinone + PKM activator TEPP-46-treated, co-treated cells after 72 h.

    PKM2-IN-1 purchased from MedChemExpress. Usage Cited in: Metabolism. 2025 Nov 6:175:156429.  [Abstract]

    Immunofluorescence images showing SPP1 expression in control and Slc2a5− /− BV2 cells treated with C3k, with OGD at various time points.

    PKM2-IN-1 purchased from MedChemExpress. Usage Cited in: EBioMedicine. 2020 Apr;54:102722.  [Abstract]

    ORO staining and quantification demonstrated that 10 μM PKM2-IN (a kinase inhibitor) could rescue the impaired adipogenic differentiation in the TRAF4-overexpressing group.

    PKM2-IN-1 purchased from MedChemExpress. Usage Cited in: EBioMedicine. 2020 Apr;54:102722.  [Abstract]

    PKM2-IN (10 μM) decreased the active β-catenin expression in the TRAF4-overexpressing group to a level near that in the NC1 group.
    • 生物活性

    • プロトコル

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    PKM2-IN-1 (compound 3k) is a pyruvate kinase M2 (PKM2) inhibitor with an IC50 of 2.95 μM[1].

    IC50 & Target

    IC50: 2.95 μM (PKM2)[1]

    Cellular Effect
    Cell Line Type Value Description References
    BEAS-2B IC50
    18.46 3
    Compound: 3k
    Cytotoxicity against human BEAS2B cells assessed as reduction in cell viability after 48 hrs by MTS assay
    Cytotoxicity against human BEAS2B cells assessed as reduction in cell viability after 48 hrs by MTS assay
    [PMID: 28688274]
    BEAS-2B IC50
    18.46 3
    Compound: 3k
    Cytotoxicity against human BEAS2B cells assessed as reduction in cell viability after 48 hrs by MTS assay
    Cytotoxicity against human BEAS2B cells assessed as reduction in cell viability after 48 hrs by MTS assay
    [PMID: 28688274]
    BEAS-2B IC50
    18.46 3
    Compound: 3k
    Cytotoxicity against human BEAS2B cells assessed as reduction in cell viability after 48 hrs by MTS assay
    Cytotoxicity against human BEAS2B cells assessed as reduction in cell viability after 48 hrs by MTS assay
    [PMID: 28688274]
    HCT-116 IC50
    0.18 3
    Compound: 3k
    Antiproliferative activity against human HCT116 cells after 48 hrs by MTS assay
    Antiproliferative activity against human HCT116 cells after 48 hrs by MTS assay
    [PMID: 28688274]
    HCT-116 IC50
    0.18 3
    Compound: 3k
    Antiproliferative activity against human HCT116 cells after 48 hrs by MTS assay
    Antiproliferative activity against human HCT116 cells after 48 hrs by MTS assay
    [PMID: 28688274]
    HCT-116 IC50
    2.95 3
    Compound: 26
    Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition
    Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition
    [PMID: 34355179]
    HeLa IC50
    0.29 3
    Compound: 3k
    Antiproliferative activity against human HeLa cells after 48 hrs by MTS assay
    Antiproliferative activity against human HeLa cells after 48 hrs by MTS assay
    [PMID: 28688274]
    HeLa IC50
    0.29 3
    Compound: 3k
    Antiproliferative activity against human HeLa cells after 48 hrs by MTS assay
    Antiproliferative activity against human HeLa cells after 48 hrs by MTS assay
    [PMID: 28688274]
    NCI-H1299 IC50
    1.56 3
    Compound: 3k
    Antiproliferative activity against human NCI-H1299 cells after 48 hrs by MTS assay
    Antiproliferative activity against human NCI-H1299 cells after 48 hrs by MTS assay
    [PMID: 28688274]
    HeLa IC50
    2.95 3
    Compound: 26
    Antiproliferative activity against human HeLa cells assessed as cell growth inhibition
    Antiproliferative activity against human HeLa cells assessed as cell growth inhibition
    [PMID: 34355179]
    NCI-H1299 IC50
    2.01 3
    Compound: 3k
    Antiproliferative activity against human NCI-H1299 cells after 48 hrs in presence of PKM2 activator FBP by MTS assay
    Antiproliferative activity against human NCI-H1299 cells after 48 hrs in presence of PKM2 activator FBP by MTS assay
    [PMID: 28688274]
    HCT-116 IC50
    0.18 3
    Compound: 3k
    Antiproliferative activity against human HCT116 cells after 48 hrs by MTS assay
    Antiproliferative activity against human HCT116 cells after 48 hrs by MTS assay
    [PMID: 28688274]
    NCI-H1299 IC50
    1.56 3
    Compound: 3k
    Antiproliferative activity against human NCI-H1299 cells after 48 hrs by MTS assay
    Antiproliferative activity against human NCI-H1299 cells after 48 hrs by MTS assay
    [PMID: 28688274]
    NCI-H1299 IC50
    2.01 3
    Compound: 3k
    Antiproliferative activity against human NCI-H1299 cells after 48 hrs in presence of PKM2 activator FBP by MTS assay
    Antiproliferative activity against human NCI-H1299 cells after 48 hrs in presence of PKM2 activator FBP by MTS assay
    [PMID: 28688274]
    HCT-116 IC50
    2.95 3
    Compound: 26
    Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition
    Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition
    [PMID: 34355179]
    NCI-H1299 IC50
    2.95 3
    Compound: 26
    Antiproliferative activity against human NCI-H1299 cells assessed as cell growth inhibition
    Antiproliferative activity against human NCI-H1299 cells assessed as cell growth inhibition
    [PMID: 34355179]
    HeLa IC50
    0.29 3
    Compound: 3k
    Antiproliferative activity against human HeLa cells after 48 hrs by MTS assay
    Antiproliferative activity against human HeLa cells after 48 hrs by MTS assay
    [PMID: 28688274]
    HeLa IC50
    2.95 3
    Compound: 26
    Antiproliferative activity against human HeLa cells assessed as cell growth inhibition
    Antiproliferative activity against human HeLa cells assessed as cell growth inhibition
    [PMID: 34355179]
    NCI-H1299 IC50
    1.56 3
    Compound: 3k
    Antiproliferative activity against human NCI-H1299 cells after 48 hrs by MTS assay
    Antiproliferative activity against human NCI-H1299 cells after 48 hrs by MTS assay
    [PMID: 28688274]
    NCI-H1299 IC50
    2.01 3
    Compound: 3k
    Antiproliferative activity against human NCI-H1299 cells after 48 hrs in presence of PKM2 activator FBP by MTS assay
    Antiproliferative activity against human NCI-H1299 cells after 48 hrs in presence of PKM2 activator FBP by MTS assay
    [PMID: 28688274]
    NCI-H1299 IC50
    2.95 3
    Compound: 26
    Antiproliferative activity against human NCI-H1299 cells assessed as cell growth inhibition
    Antiproliferative activity against human NCI-H1299 cells assessed as cell growth inhibition
    [PMID: 34355179]
    体外実験

    PKM2-IN-1 (compound 3k) is a pyruvate kinase M2 (PKM2) inhibitor with an IC50 of 2.95±0.53 μM. Results show that most of the tested compounds exhibit some degree of PKM2 inhibition and some compounds, such as PKM2-IN-1 (compound 3k) and 6d, display more potent activity than the positive control shikonin. The representative compounds PKM2-IN-1, 6d display dose-dependent inhibition of PKM2 with less inhibition of PKM1 and PKL like shikonin. Among all tested compounds, the most potent compounds are 3a, PKM2-IN-1 and 3r, which exhibit IC50 values against HCT116 and Hela cells ranging from 0.39 to 0.41 μM, 0.18 to 0.29 μM and 0.18 to 0.38 μM, respectively[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    分子量

    345.48

    分子式

    C18H19NO2S2

    CAS 番号
    Appearance

    Solid

    Color

    Light yellow to yellow

    SMILES

    S=C(N1CCCCC1)SCC(C2=O)=C(C)C(C3=C2C=CC=C3)=O

    輸送条件

    Room temperature in continental US; may vary elsewhere.

    保管条件
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    DMSO : 4 mg/mL (11.58 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.8945 mL 14.4726 mL 28.9452 mL
    5 mM 0.5789 mL 2.8945 mL 5.7890 mL
    10 mM 0.2895 mL 1.4473 mL 2.8945 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始)

    C1

    ×
    体積 (開始)

    V1

    =
    濃度 (終了)

    C2

    ×
    体積 (終了)

    V2

    体内:

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  15% Cremophor EL    85% Saline

      Solubility: 25 mg/mL (72.36 mM); Suspended solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    純度とドキュメンテーション

    純度: 99.79%

    参考文献
    細胞実験
    [1]

    Cell lines (HCT116, Hela, H1299, BEAS-2B) are cultured in RPMI 1640 containing 9% fetal bovine serum (FBS) at 37°C in 5% CO2. Cell viability is detected with the MTS assay according to the manufacturer's instructions. Briefly, 5000 cells in per well are plated in 96-well plates. After incubated for 12 h, the cells are treated with different concentration of tested compound (including PKM2-IN-1) or DMSO (as negative control) for 48 h. Then 20 μL MTS is added in per well and incubated at 37°C for 3 h. Absorbance of each well is determined by a microplate reader at a 490 nm wavelength. The IC50 values are calculated using Prism Graphpad software of the triplicate experiment[1].

    MedChemExpress (MCE) はこれらの方法の精度を確認していません。 こちらは参照専用です。

    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 2.8945 mL 14.4726 mL 28.9452 mL 72.3631 mL
    5 mM 0.5789 mL 2.8945 mL 5.7890 mL 14.4726 mL
    10 mM 0.2895 mL 1.4473 mL 2.8945 mL 7.2363 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

     

    カスタマ需要量 *

    お名前 *

     

    タイトル

    メールアドレス *

     

    電話番号 *

    デパートメント

     

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

         

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    PKM2-IN-1
    製品番号:
    HY-103617
    数量:
    MCE 日本正規代理店: